I wouldn't read too much into it. Their law firm
Post# of 30027
Posted On: 11/23/2015 5:59:48 PM
I wouldn't read too much into it. Their law firm is incredibly sloppy.
They also included language about the Georgetown option like it is still in play.
And I can't figure out exactly what the Nerveda Warrants are. There are words missing in their description of that.
They also included language about the Georgetown option like it is still in play.
And I can't figure out exactly what the Nerveda Warrants are. There are words missing in their description of that.
Quote:
"For the next 12 months, we intend to focus primarily on the commercialization of LymPro, the further clinical development of Eltoprazine, and the preclinical development of MANF."
NO ESS OR MSPRECISE?????
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼